Crossmark

Lessons learned from IDeAl — 33 recommendations from the IDeAl-net about design and analysis of small population clinical trials

Crossref DOI link: https://doi.org/10.1186/s13023-018-0820-8

Published Online: 2018-05-11

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hilgers, Ralf-Dieter https://orcid.org/0000-0002-5945-1119
Bogdan, Malgorzata

Burman, Carl-Fredrik

Dette, Holger

Karlsson, Mats

König, Franz

Male, Christoph

Mentré, France

Molenberghs, Geert

Senn, Stephen
Funding

Funding for this research was provided by:

FP7 Health (602552)
License Information

Text and Data Mining valid from 2018-05-11
More Information

Article History

Received: 2 November 2017

Accepted: 1 May 2018

First Online: 11 May 2018

Ethics approval and consent to participate

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.